Alcohol Septal Ablation for Left Ventricle Outflow Tract Obstruction Prevention Before Transcatheter Mitral Valve Replacement Procedure: Computed Tomography Analysis Series
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Ayoub Belfekih und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Institut Mutualiste Montsouris, Paris, France. Hauptthemen laut MEDLINE: Ventricular Outflow Obstruction, Cardiac Catheterization, Heart Valve Prosthesis Implantation, Mitral Valve. Die Arbeit nennt 24 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Left ventricle outflow tract obstruction (LVOTO) is the main limitation of transcatheter mitral valve replacement (TMVR) procedure occurring in 7%−9% of cases and responsible of 25% TMVR screen failures.
Aims
We aim to assess the alcohol septal ablation (ASA) effect on LVOTO risk before TMVR by multistage cardiac computed tomography (CT).
Methods
Patients indicated for TMVR procedure using Sapiens 3 Prosthesis with high LVOTO risk were enrolled in the study. ASA was the first choice technique to reduce this risk based on multiple and staged cardiac CT screening.
Results
Out of 29 consecutive TMVR procedures conducted in our center between March 2021 and April 2023, nine patients presented high LVOTO risk and were enrolled in our study. The main risk factor retained was a reduced predicted NeoLVOT surface 89 mm 2 [66−135] (< 170 mm 2 ). Most procedures were valve in MAC and all patients underwent at least one ASA. CT control showed a significant increase by 95% in the predicted NeoLVOT surface: 174 mm 2 [121−240]; p = 0.012 compared to the baseline value. There were no significant paraprosthesis leakage or LVOTO found on TTE according to the MVARC criteria. Cardiac CT showed a larger than predicted final NeoLVOT surface: 215 mm 2 [175−317]; p = 0.018. One patient died after ASA, and two others during the first year of follow‐up. Survivors had significant symptom relief ( p = 0.046) and a decreased PASP (38 mmHg [32−47] vs. 54 mmHg [46−62.5]; p = 0.028).
Conclusions
Multistage CT analysis shows that ASA is effective in high LVOTO‐risk patients undergoing TMVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, Institut Mutualiste Montsouris, Paris, France.
ORCID-Profile: Ayoub Belfekih, Nicolas Amabile
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Belfekih, A., Masri, A., Veugeois, A., Diakov, C., Mahmoudi, K., Ribeyrolles, S., Mami, Z., Roig, C., Amabile, N., & Caussin, C. (2025). Alcohol Septal Ablation for Left Ventricle Outflow Tract Obstruction Prevention Before Transcatheter Mitral Valve Replacement Procedure: Computed Tomography Analysis Series. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31446
Vancouver
Belfekih A, Masri A, Veugeois A, Diakov C, Mahmoudi K, Ribeyrolles S, et al. Alcohol Septal Ablation for Left Ventricle Outflow Tract Obstruction Prevention Before Transcatheter Mitral Valve Replacement Procedure: Computed Tomography Analysis Series. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31446
BibTeX
@article{Belfekih2025,
author = {Belfekih, Ayoub and Masri, Alaa and Veugeois, Aurélie and Diakov, Christelle and Mahmoudi, Khalil and Ribeyrolles, Sophie and Mami, Zoheir and Roig, Clemence and Amabile, Nicolas and Caussin, Christophe},
title = {Alcohol Septal Ablation for Left Ventricle Outflow Tract Obstruction Prevention Before Transcatheter Mitral Valve Replacement Procedure: Computed Tomography Analysis Series},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31446}
}
EUVIMED